Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infants.

[1]  G. Kang,et al.  A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants , 2018, Vaccine.

[2]  N. Gogtay,et al.  Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine☆ , 2018, Vaccine.

[3]  M. Bhan,et al.  A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India , 2018, Human vaccines & immunotherapeutics.

[4]  P. Kulkarni,et al.  Safety and tolerability of a liquid bovine rotavirus pentavalent vaccine (LBRV-PV) in adults. , 2018, Vaccine.

[5]  G. Kang,et al.  A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants , 2017, Vaccine.

[6]  E. Burnett,et al.  Effectiveness of Rotavirus Vaccination: A Systematic Review of the First Decade of Global Postlicensure Data, 2006–2016 , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  R. Montesano,et al.  Impact of rotavirus vaccination on child mortality, morbidity, and rotavirus-related hospitalizations in Bolivia. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[8]  J. Tate,et al.  Impact and cost-effectiveness of rotavirus vaccination in Bangladesh , 2017, Vaccine.

[9]  S. Gairola,et al.  Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL®). , 2017, Vaccine.

[10]  R. Grais,et al.  Efficacy of a Low‐Cost, Heat‐Stable Oral Rotavirus Vaccine in Niger , 2017, The New England journal of medicine.

[11]  B. M. Machado,et al.  The impact of rotavirus vaccination on emergency department visits and hospital admissions for acute diarrhea in children under 5 years. , 2016, Revista da Associacao Medica Brasileira.

[12]  L. Cuevas,et al.  Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis , 2016, Infectious Diseases of Poverty.

[13]  J. Tate,et al.  Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  P. Kulkarni,et al.  Bovine rotavirus pentavalent vaccine development in India. , 2014, Vaccine.

[15]  G. Kang,et al.  Human and bovine rotavirus strain antigens for evaluation of immunogenicity in a randomized, double-blind, placebo-controlled trial of a single dose live attenuated tetravalent, bovine-human-reassortant, oral rotavirus vaccine in Indian adults. , 2014, Vaccine.

[16]  S. Bhave,et al.  Immunogenicity and safety of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine (PRV) in Indian infants , 2013, Human vaccines & immunotherapeutics.

[17]  T. Vesikari,et al.  Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 oral suspension (liquid formulation) in Finnish infants. , 2011, Vaccine.

[18]  G. Kang,et al.  Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants , 2009, Human vaccines.